As of the 12th of February 2026, Helix BioPharma retains the Market Risk Adjusted Performance of (0.13), risk adjusted performance of (0.01), and Standard Deviation of 4.06. Helix BioPharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Helix, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Helix
Helix
Helix BioPharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Please note, there is a significant difference between Helix BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helix BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Helix BioPharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Helix BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Helix BioPharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Helix BioPharma.
0.00
11/14/2025
No Change 0.00
0.0
In 3 months and 1 day
02/12/2026
0.00
If you would invest 0.00 in Helix BioPharma on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Helix BioPharma Corp or generate 0.0% return on investment in Helix BioPharma over 90 days. Helix BioPharma is related to or competes with Satellos Bioscience, Cannara Biotech, HLS Therapeutics, Medicenna Therapeutics Cor, Cardiol Therapeutics, Quipt Home, and Sernova Corp. Helix BioPharma Corp., an immune-oncology company, focuses on the development of cancer drugs in Canada More
Helix BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Helix BioPharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Helix BioPharma Corp upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Helix BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Helix BioPharma's standard deviation. In reality, there are many statistical measures that can use Helix BioPharma historical prices to predict the future Helix BioPharma's volatility.
Helix BioPharma Corp holds Efficiency (Sharpe) Ratio of -0.0778, which attests that the entity had a -0.0778 % return per unit of risk over the last 3 months. Helix BioPharma Corp exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Helix BioPharma's Standard Deviation of 4.06, market risk adjusted performance of (0.13), and Risk Adjusted Performance of (0.01) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.56, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Helix BioPharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Helix BioPharma is expected to be smaller as well. At this point, Helix BioPharma Corp has a negative expected return of -0.32%. Please make sure to check out Helix BioPharma's treynor ratio, as well as the relationship between the daily balance of power and price action indicator , to decide if Helix BioPharma Corp performance from the past will be repeated at some point in the near future.
Auto-correlation
0.13
Insignificant predictability
Helix BioPharma Corp has insignificant predictability. Overlapping area represents the amount of predictability between Helix BioPharma time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Helix BioPharma Corp price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Helix BioPharma price fluctuation can be explain by its past prices.
Correlation Coefficient
0.13
Spearman Rank Test
0.23
Residual Average
0.0
Price Variance
0.04
Helix BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Helix BioPharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Helix BioPharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Helix BioPharma Corp Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Helix BioPharma Corp across different markets.
About Helix BioPharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Helix BioPharma Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Helix BioPharma Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Helix BioPharma Corp price pattern first instead of the macroeconomic environment surrounding Helix BioPharma Corp. By analyzing Helix BioPharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Helix BioPharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Helix BioPharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Helix BioPharma February 12, 2026 Technical Indicators
Most technical analysis of Helix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Helix from various momentum indicators to cycle indicators. When you analyze Helix charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Helix BioPharma February 12, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Helix stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Helix BioPharma financial ratios help investors to determine whether Helix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioPharma security.